Browse EV MemProt Atlas
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| DSC2 | Q02487 | Desmocollin-2 (Cadherin family member 2) (Desmocollin-3) (Desmosomal glycoprotein II) (Desmosomal glycoprotein III) | Disease related genesHuman disease related genesPlasma proteins | 1 | Adhesion and uptake mediationFusion and delivery mediation | 7 | 0.63 | |||
| MOT4 | O15427 | Monocarboxylate transporter 4 (MCT 4) (Solute carrier family 16 member 3) | Metabolic proteinsPredicted membrane proteinsTransporters | 12 | Fusion and delivery mediationImmune mediation | 7 | 0.63 | |||
| MRP6 | O95255 | ATP-binding cassette sub-family C member 6 (EC 7.6.2.-) (EC 7.6.2.3) (Anthracycline resistance-associated protein) (Multi-specific organic anion transporter E) (MOAT-E) (Multidrug resistance-associated protein 6) | 17 | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 7 | 0.63 | ||||
| MUC1 | P15941 | Mucin-1 (MUC-1) (Breast carcinoma-associated antigen DF3) (Cancer antigen 15-3) (CA 15-3) (Carcinoma-associated mucin) (Episialin) (H23AG) (Krebs von den Lungen-6) (KL-6) (PEMT) (Peanut-reactive urinary mucin) (PUM) (Polymorphic epithelial mucin) (PEM) (Tumor-associated epithelial membrane antigen) (EMA) (Tumor-associated mucin) (CD antigen CD227) [Cleaved into: Mucin-1 subunit alpha (MUC1-NT) (MUC1-alpha); Mucin-1 subunit beta (MUC1-beta) (MUC1-CT)] | Cancer-related genesCD markersDisease related genes | 1 | Acute myeloid leukaemiaBipolar disorderBrain cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 7 | 0.63 | ||
| ODR4 | Q5SWX8 | Protein odr-4 homolog (hODR-4) (LAG1-interacting protein) (Transactivated by transforming growth factor beta protein 1) | Predicted membrane proteins | 2 | Other mediation | 7 | 0.63 | |||
| OLFM4 | Q6UX06 | Olfactomedin-4 (OLM4) (Antiapoptotic protein GW112) (G-CSF-stimulated clone 1 protein) (hGC-1) (hOLfD) | Predicted secreted proteins | Adhesion and uptake mediationImmune mediation | 7 | 0.63 | ||||
| PAR4 | Q96RI0 | Proteinase-activated receptor 4 (PAR-4) (Coagulation factor II receptor-like 3) (Thrombin receptor-like 3) | 7 | Fusion and delivery mediationImmune mediationMetabolism mediation | 7 | 0.63 | ||||
| PCDBG | Q9NRJ7 | Protocadherin beta-16 (PCDH-beta-16) (Protocadherin-3X) | 1 | Adhesion and uptake mediation | 7 | 0.63 | ||||
| PDE4D | Q08499 | 3',5'-cyclic-AMP phosphodiesterase 4D (EC 3.1.4.53) (DPDE3) (PDE43) (cAMP-specific phosphodiesterase 4D) | Disease related genesEnzymesFDA approved drug targets | Acute upper respiratory infectionAllergic/hypersensitivity disorderAlzheimer disease | Clinical-translation mediationFusion and delivery mediationImmune mediation | 7 | 0.63 | |||
| SRC8 | Q14247 | Src substrate cortactin (Amplaxin) (Oncogene EMS1) | Cancer-related genesPlasma proteinsPredicted intracellular proteins | Adhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation | 7 | 0.63 | ||||
| UFO | P30530 | Tyrosine-protein kinase receptor UFO (EC 2.7.10.1) (AXL oncogene) | Disease related genesEnzymesFDA approved drug targets | 1 | Acute myeloid leukaemiaBreast cancerKaposi sarcoma | Adhesion and uptake mediationClinical-translation mediationImmune mediation | 7 | 0.63 | ||
| XRN1 | Q8IZH2 | 5'-3' exoribonuclease 1 (EC 3.1.13.-) (Strand-exchange protein 1 homolog) | Essential proteinsPredicted intracellular proteins | Clinical-translation mediation | 7 | 0.63 | ||||
| AA1R | P30542 | Adenosine receptor A1 | FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins | 7 | Acute diabete complicationAllergic/hypersensitivity disorderCardiac arrhythmia | Clinical-translation mediationFusion and delivery mediationImmune mediation | 6 | 0.63 | ||
| ANO10 | Q9NW15 | Anoctamin-10 (Transmembrane protein 16K) | Disease related genesHuman disease related genesPotential drug targets | 8 | Clinical-translation mediationFusion and delivery mediation | 6 | 0.63 | |||
| ARHGC | Q9NZN5 | Rho guanine nucleotide exchange factor 12 (Leukemia-associated RhoGEF) | Cancer-related genesDisease related genesPredicted intracellular proteins | Receptor-signaling mediation | 6 | 0.63 | ||||
| BACE1 | P56817 | Beta-secretase 1 (EC 3.4.23.46) (Aspartyl protease 2) (ASP2) (Asp 2) (Beta-site amyloid precursor protein cleaving enzyme 1) (Beta-site APP cleaving enzyme 1) (Memapsin-2) (Membrane-associated aspartic protease 2) | EnzymesPredicted intracellular proteinsPredicted membrane proteins | 1 | Alzheimer disease | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 6 | 0.63 | ||
| CAH14 | Q9ULX7 | Carbonic anhydrase 14 (EC 4.2.1.1) (Carbonate dehydratase XIV) (Carbonic anhydrase XIV) (CA-XIV) | EnzymesFDA approved drug targetsMetabolic proteins | 1 | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 6 | 0.63 | |||
| CHIC2 | Q9UKJ5 | Cysteine-rich hydrophobic domain-containing protein 2 (BrX-like translocated in leukemia) | Disease related genesHuman disease related genesPredicted intracellular proteins | Fusion and delivery mediation | 6 | 0.63 | ||||
| CSF1R | P07333 | Macrophage colony-stimulating factor 1 receptor (CSF-1 receptor) (CSF-1-R) (CSF-1R) (M-CSF-R) (EC 2.7.10.1) (Proto-oncogene c-Fms) (CD antigen CD115) | Cancer-related genesCD markersDisease related genes | 1 | Alzheimer diseaseBone/articular cartilage neoplasmDiabetes mellitus | Clinical-translation mediationImmune mediationReceptor-signaling mediation | 6 | 0.63 | ||
| FGD5 | Q6ZNL6 | FYVE, RhoGEF and PH domain-containing protein 5 (Zinc finger FYVE domain-containing protein 23) | Predicted intracellular proteins | Fusion and delivery mediationReceptor-signaling mediation | 6 | 0.63 | ||||
| FGR | P09769 | Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog) (Proto-oncogene c-Fgr) (p55-Fgr) (p58-Fgr) (p58c-Fgr) | Disease related genesEnzymesPlasma proteins | Clinical-translation mediationFusion and delivery mediationImmune mediation | 6 | 0.63 | ||||
| HRH1 | P35367 | Histamine H1 receptor (H1-R) (H1R) (HH1R) | FDA approved drug targetsG-protein coupled receptorsPredicted intracellular proteins | 7 | Clinical-translation mediationReceptor-signaling mediation | 6 | 0.63 | |||
| I12R1 | P42701 | Interleukin-12 receptor subunit beta-1 (IL-12 receptor subunit beta-1) (IL-12R subunit beta-1) (IL-12R-beta-1) (IL-12RB1) (IL-12 receptor beta component) (CD antigen CD212) | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 6 | 0.63 | ||||
| INSR | P06213 | Insulin receptor (IR) (EC 2.7.10.1) (CD antigen CD220) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] | CD markersDisease related genesEnzymes | 1 | Acute diabete complicationAlzheimer diseaseBreast cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 6 | 0.63 | ||
| ITB3 | P05106 | Integrin beta-3 (Platelet membrane glycoprotein IIIa) (GPIIIa) (CD antigen CD61) | Cancer-related genesCD markersDisease related genes | 1 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 6 | 0.63 |